MyFinsight
Home
About
Contact
tbph: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, TBPH has $415,460K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
415,460
426,035
Total liabilities and shareholders' equity
415,460
426,035
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Other prepaid and
current assets
$6,750K
Receivables from
collaborative arrangements
$18,267K
Short-term marketable
securities
$154,907K
Cash and cash
equivalents
$174,773K
Other assets
$25,191K
Restricted cash
$836K
Operating lease assets
$25,450K
Property and equipment,
net
$6,257K
Long-term marketable
securities
$3,029K
Total current assets
$354,697K
Total assets
$415,460K
Total liabilities and
shareholders' equity
$415,460K
Total shareholders'
equity
$232,681K
Other long-term
liabilities
$313K
Unrecognized tax benefits
$79,165K
Future royalty payment
contingency
$32,213K
Long-term operating lease
liabilities
$33,681K
Total current
liabilities
$37,407K
Accumulated deficit
-$920,651K
Accumulated other
comprehensive income
$32K
Additional paid-in capital
$1,153,299K
Other accrued
liabilities
$1,335K
Income tax payable
$4,074K
Operating lease
liabilities
$10,914K
Accrued general and
administrative expenses
$2,699K
Accrued clinical and
development expenses
$5,842K
Accrued
personnel-related expenses
$10,330K
Accounts payable
$2,213K
Ordinary shares, 0.00001
par value per share...
$1K
Subscribe for Financial Insights
Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH)